Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OM:SIVE
OM:SIVESemiconductor

Sivers Semiconductors (OM:SIVE) Revenue Set to Grow 21% Annually, Losses Narrowing—Earnings Preview

Sivers Semiconductors (OM:SIVE) remains unprofitable, but its revenue is projected to grow at an impressive 21% per year. This pace is well ahead of the Swedish market's 3.8% rate. Over the past five years, the company's losses have narrowed at a rate of 8.1% per year, though forecasts suggest it will remain in the red for at least the next three years. Investors are likely to focus on ongoing revenue growth and shrinking losses as they weigh the prospects for eventual profitability in light...
NasdaqGS:CSGS
NasdaqGS:CSGSProfessional Services

How Investors May Respond To CSG Systems International's (CSGS) New Formula 1 Partnership for Brand Expansion

MoneyGram Haas F1 Team recently announced a new partnership with CSG Systems International, debuting their collaboration at the 2025 Formula 1 United States Grand Prix in Austin, Texas, to emphasize their shared commitment to innovation and performance. This partnership leverages the global exposure and fast-paced environment of Formula 1 racing to highlight CSG's expertise in empowering brands to engage customers and manage complexity. We'll now examine how CSG's new Formula 1 alliance...
NasdaqGM:ARCT
NasdaqGM:ARCTBiotechs

Arcturus Therapeutics (ARCT): Evaluating Valuation After Cystic Fibrosis Trial Setback and Heightened Regulatory Scrutiny

Arcturus Therapeutics Holdings (ARCT) drew intense investor attention after it released interim results from a Phase 2 trial for its cystic fibrosis treatment, ARCT-032. The report showed no substantial lung function improvement, which triggered sharp share declines and analyst downgrades. See our latest analysis for Arcturus Therapeutics Holdings. It has been a turbulent year for Arcturus Therapeutics. Shares have dropped sharply after underwhelming trial news and legal scrutiny, leading to...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

Assessing Atomera (ATOM) Valuation as Investors Await Significant Revenue Growth in Upcoming Earnings

Atomera (ATOM) is gearing up for its latest earnings report, and expectations are high for a substantial jump in quarterly revenue compared to the same period last year. Investors are watching closely to see how this development will shape the company’s outlook. See our latest analysis for Atomera. Despite anticipation around the upcoming earnings, Atomera’s recent share price momentum has been firmly negative, with a 7-day return of -31.37% and a one-year total shareholder return of -6.25%...
NasdaqCM:COYA
NasdaqCM:COYABiotechs

Coya Therapeutics (COYA): Evaluating Valuation After Equity Raise and Milestone Progress in ALS Program

Coya Therapeutics has completed a $20 million follow-on equity offering. The company aims to strengthen its cash position and accelerate progress in the Phase 2 trial of COYA 302, its experimental ALS therapy. Investors are watching these milestones closely, as the FDA's recent acceptance of Coya's drug application and a triggered milestone payment bring new attention to the company’s clinical and financial strategy. See our latest analysis for Coya Therapeutics. After announcing the equity...
ASX:ASM
ASX:ASMMetals and Mining

Australian Strategic Materials (ASX:ASM): Evaluating Valuation Following $55m Raise and Rare Earths Expansion Plans

Australian Strategic Materials (ASX:ASM) just wrapped up a $55 million institutional placement, fueling the Phase 2 expansion of its Korean Metals Plant. This move is expected to double neodymium alloy production and broaden the company’s role in rare earth supply chains. See our latest analysis for Australian Strategic Materials. It has been a wild ride for Australian Strategic Materials’ share price lately. After a huge 92.7% surge in the past month, driven by the capital raise and plans to...
NasdaqCM:ETHZ
NasdaqCM:ETHZBiotechs

ETHZilla (ETHZ): Evaluating Valuation After $15 Million Liquidity.io Partnership and Strategic Platform Expansion

ETHZilla is drawing attention after unveiling a $15 million strategic partnership with Satschel, Inc., parent of Liquidity.io. This collaboration gives ETHZilla a 15% equity stake as well as exclusive rights within regulated digital asset markets. See our latest analysis for ETHZilla. Momentum has picked up again for ETHZilla after the Satschel investment, with the share price jumping 17.38% in just the last day and 7.32% over the past week, though recent news-fueled rallies come against the...
NYSE:WEC
NYSE:WECIntegrated Utilities

Is WEC Energy Group Fairly Priced After 23% Climb and Renewable Energy Headlines?

Thinking about whether to buy, sell, or simply hold WEC Energy Group stock? You’re definitely not alone. WEC has been a staple for many portfolios, and its share price reflects that consistency. Over the last year, the stock has climbed 23.3%. For longer-term investors, the gains are even more solid, with a 40.8% increase over the last three years and 35.9% over five years. Even its performance year to date hasn’t gone unnoticed, jumping 23.2%. That said, the past week brought a modest 0.9%...
OTCPK:LAZR.Q
OTCPK:LAZR.QAuto Components

Is Luminar (LAZR) Prioritizing Prestigious Partnerships Over Near-Term Financial Stability?

Earlier this week, Luminar Technologies announced that its lidar technology is now integrated into Volvo’s EX90 and is being included on platforms from Mercedes-Benz, NVIDIA, and Mobileye, while it also provided updates on its next-generation “Halo” chipset and production plans for late 2025 and early 2026. An interesting takeaway is that despite these prominent partnerships and advancements, the company revised its full-year 2025 guidance downward due to slower automotive ramp-up, winding...
SEHK:1313
SEHK:1313Basic Materials

China Resources Cement (SEHK:1313) One-Off CN¥257.5m Loss Challenges Earnings Recovery Narrative

China Resources Building Materials Technology Holdings (SEHK:1313) reported a one-off loss of CN¥257.5 million over the twelve months to 30th September 2025, which dragged its net profit margin down to 1%, compared to 1.4% last year. Over the last five years, earnings have declined at an average rate of 60.9% per year, with earnings growth turning negative in the latest period. This has pushed recent performance far below its longer-term trends. Despite these setbacks, analyst forecasts point...
NasdaqCM:ORBS
NasdaqCM:ORBSPackaging

Eightco Holdings (ORBS): Evaluating Valuation After Worldcoin Reserve Shift and Dan Ives Appointment

Eightco Holdings (ORBS) is in the spotlight again after its move to adopt Worldcoin as a primary reserve asset and bring Dan Ives on board as chairman. This shake-up has sparked renewed interest and rapid price swings. See our latest analysis for Eightco Holdings. ORBS has seen one of the most dramatic runs among speculative stocks this year, with the 1-year total shareholder return at nearly 231%. Yet, this surge comes after years of heavy losses, a delisting, and repeated pivoting between...
SWX:SIKA
SWX:SIKAChemicals

Sika (SWX:SIKA) Forecasts 10% Annual Earnings Growth, Reinforcing Bullish Narratives Ahead of Earnings

Sika (SWX:SIKA) delivered earnings forecast to grow at 10% per year, with revenue set to rise by 4.7% annually, outpacing the broader Swiss market’s projected 4% growth rate. Over the past five years, earnings have climbed by 6.9% each year, and the company has maintained a net profit margin of 10.5%, matching the prior period. These numbers, paired with Sika’s high-quality earnings profile and only minor risk concerns, provide investors with a constructive outlook anchored by continued...
TSX:XTRA
TSX:XTRAAerospace & Defense

Xtract One Technologies (TSX:XTRA) Losses Narrow, Undervalued Against Peers Heading Into Earnings Season

Xtract One Technologies (TSX:XTRA) remains unprofitable, but annual losses have narrowed by 9.7% per year over the last five years. Shares trade at CA$0.71, notably below the company’s estimated fair value of CA$1.6. While not yet profitable, the consistent reduction in losses could prompt investors to see operational improvement on the horizon. See our full analysis for Xtract One Technologies. Next, we will see how these figures stack up against the narratives shaping market sentiment,...
NasdaqCM:FLUX
NasdaqCM:FLUXElectrical

Flux Power Holdings (FLUX): Assessing Valuation Following Return to Nasdaq Compliance and Renewed Market Confidence

Flux Power Holdings (FLUX) has regained compliance with Nasdaq’s listing rules after facing a potential delisting. This development is likely to boost investor confidence and renew interest in the company’s prospects. See our latest analysis for Flux Power Holdings. Regaining Nasdaq compliance comes after a dramatic surge in Flux Power Holdings’ share price, with a 30-day share price return of 85.5% and a striking year-to-date gain of 252.9%. That momentum has reignited interest, especially...
SEHK:2689
SEHK:2689Forestry

Nine Dragons Paper (SEHK:2689) Profit Margins Double, Reinforcing Bullish Earnings Narratives

Nine Dragons Paper (Holdings) (SEHK:2689) reported a net profit margin of 2.8%, up from 1.3% the previous year, with earnings growth of 135.4% over the last twelve months. While revenue is forecast to grow by 5.3% per year and earnings are expected to increase by 20.3% annually, these figures show the company’s earnings momentum now outpacing the Hong Kong market average. For investors, the key story is accelerating profit improvement alongside robust earnings quality. However, questions...
SEHK:1088
SEHK:1088Oil and Gas

China Shenhua Energy (SEHK:1088) Revenue Growth Trails Market, Challenging Bullish Valuation Narratives

China Shenhua Energy (SEHK:1088) reported annual revenue growth of 1.5%, trailing behind the broader Hong Kong market’s 8.6% growth rate. EPS trends have come under pressure, with a 7% compound annual growth rate over five years giving way to negative earnings growth in the past year and forecasts pointing to a 1% annual decline over the next three years. Despite net profit margins holding steady at 17.6%, just shy of last year's 17.7%, the latest results highlight a challenging outlook and...
SEHK:488
SEHK:488Real Estate

Lai Sun Development (SEHK:488) Losses Accelerate, Sustaining Deep Discount and Bearish Market Narrative

Lai Sun Development (SEHK:488) remains unprofitable, with losses accelerating at an average rate of 4.2% per year over the last five years. Net profit margins have stalled with no visible improvement, and earnings growth was not measurable due to persistent unprofitability. With profits showing no signs of acceleration and no evidence of meaningful past earnings quality, investors are left with a stock trading at a price-to-sales ratio of just 0.2x, which is far below both the industry and...
SEHK:3323
SEHK:3323Basic Materials

China National Building Material (SEHK:3323) Earnings Surge 630.7%, Challenging Bearish Narratives on Profitability

China National Building Material (SEHK:3323) delivered a striking 630.7% earnings growth over the past year, rebounding after averaging a 35.5% annual decline for the prior five years. Net profit margins also climbed sharply, moving from 0.4% a year ago to 3.3%. Despite this headline improvement, current forecasts point to a 0.6% annual decline in future earnings and a modest 3.2% revenue growth rate. Both figures trail the broader Hong Kong market. See our full analysis for China National...
NYSEAM:PMI
NYSEAM:PMIMedical Equipment

Picard Medical (PMI): Valuation Reassessed After Equity Plan Sparks Dilution Concerns and Stock Drop

Picard Medical (PMI) shares dropped sharply after the company’s recent SEC filing revealed an expanded equity incentive plan. The filing increased authorized shares and added new types of stock awards, sparking fresh concerns over possible shareholder dilution. See our latest analysis for Picard Medical. The latest shakeup at Picard Medical comes on the heels of its recent IPO and the unveiling of new patents for its artificial heart technology. However, none of that cushioned the blow from...
OM:YUBICO
OM:YUBICOSoftware

Yubico (OM:YUBICO) Valuation in Focus After Dashlane Partnership Sparks Passwordless Security Innovation

Yubico (OM:YUBICO) is drawing fresh attention after teaming up with Dashlane to roll out hardware-backed, passwordless authentication. The new integration uses YubiKey to provide truly passwordless, phishing-resistant logins for Dashlane users. See our latest analysis for Yubico. Despite Yubico’s headline-making partnership with Dashlane, investor sentiment has soured, with the stock experiencing a sharp drop. Its 1-day share price return stands at -26.40%, contributing to a year-to-date...
HLSE:METSB
HLSE:METSBPackaging

Metsä Board (HLSE:METSB): Losses Deepen as Volatility Challenges Optimistic Earnings Growth Narrative

Metsä Board Oyj (HLSE:METSB) is currently unprofitable, with losses widening at a rate of 34% per year over the past five years. Looking ahead, revenue is forecast to grow 5.3% annually while earnings are expected to surge by 85.57% per year. This puts the company on track for profitability within the next three years. Investors will likely weigh the promise of rapid earnings growth and a path back to profit against the recent track record of mounting losses and ongoing share price...